1.
Myxovirus resistance, osteopontin and suppressor of cytokine signaling 3 polymorphisms predict hepatitis C virus therapy response in an admixed patient population: comparison with IL28B. Clinics. 2013;68(10):1325-1332. doi:10.1590/clin.v68i10.77009